Drug · DIN 00360422
CEENU
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 29, 2026; first marketed December 31, 1976.
- Drug Identification Number (DIN)
- 00360422
- Company (DIN owner)
- Septa Pharmaceuticals IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Lomustine L01AD02
- Class
- Human
- Record last updated
- July 14, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LOMUSTINE | 40 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 29, 2026: NOC 37788New Drug Submission (NDS) · Administrative: Change in product ownership
- February 24, 2009: NOC 10060New Drug Submission (NDS) · Manufacturer name change
Other DINs named CEENU
- DIN 00360430 · Marketed
- DIN 00360414 · Cancelled Post Market